Owners, management and financials
CVR: 32141064
Secondary names: Epista IT A/S, Epista Automation Technologies A/S, Genau & More A/S
Previous names: EPISTA IT ApS, EPISTA IT A/S
DKK 104,009,512
Gross profit
Net result: DKK -40,340,814
Enhance BidCo ApS (100%)
CVR · view owners
Per Erik Mikael Johansson
Board: Simon Carl Vilhelm Larsson (chair) and 2 members
CVR · view management
Active
Founded 29 April 2009
CVR · view overview
92 employees
CVR · 2026
Director role ended: Klavs Esbjerg
CVR · 31/01/2026
View the full event history
Epista Life Science A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named EPISTA IT A/S and EPISTA IT ApS. The management consists of Per Erik Mikael Johansson. The board consists of Simon Carl Vilhelm Larsson (chair), Katarína Larsen and Klavs Esbjerg. The company is owned by Enhance BidCo ApS. The company has 92 employees (2026). In 2025, the company reported a gross profit of DKK 104,009,512 and a net result of DKK -40,340,814 compared with DKK -12,458,230 the year before. Equity in the 2025 report amounted to DKK 42,811,282.
Source: annual report 2025, Danish Business Authority
The financial health of Epista Life Science A/S shows a concerning trajectory, with significant fluctuations in profitability over recent years. In 2025, the company reported a gross profit of 104 million DKK but incurred a loss of 40 million DKK, indicating potential operational challenges. Despite a notable increase in equity from 14.7 million DKK in 2021 to 42.8 million DKK in 2025, the declining profit trend from 2024 onwards raises concerns about sustainability. The company operates in the computer consulting and facility management sector, but its lack of disclosed revenue makes it difficult to assess its market position accurately. Overall, while equity growth is a positive sign, the recent losses and profit instability suggest a need for strategic reassessment.
AI-generated summary · Generated 14/08/2026
Selskabets formål er at drive handel og industri.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 104 mio. | -40.3 mio. | 140.3 mio. | 42.8 mio. | 105 | |
| 202401/01/2024 – 31/12/2024 | 80.9 mio. | -12.5 mio. | 165 mio. | 29.3 mio. | 69 | |
| 202301/01/2023 – 31/12/2023 | 79.7 mio. | 10.5 mio. | 81.3 mio. | 39 mio. | 48 | |
| 202201/01/2022 – 31/12/2022 | 46.8 mio. | 4.7 mio. | 54.1 mio. | 28.8 mio. | 51 | |
| 202101/01/2021 – 31/12/2021 | 48.2 mio. | 9.1 mio. | 25.2 mio. | 14.7 mio. | 48 | |
| 202001/01/2020 – 31/12/2020 | 38.1 mio. | 4 mio. | 24.2 mio. | 8.6 mio. | 31 | |
| 201901/01/2019 – 31/12/2019 | 30.8 mio. | 3.4 mio. | 15.3 mio. | 6.6 mio. | 31 | |
| 201801/01/2018 – 31/12/2018 | 26.5 mio. | 483 t. | 12.8 mio. | 3.2 mio. | 31 | |
| 201701/01/2017 – 31/12/2017 | 23.7 mio. | 1.3 mio. | 9.8 mio. | 3.5 mio. | 27 | |
| 201601/01/2016 – 31/12/2016 | 19.9 mio. | -884 t. | 7.9 mio. | 1.7 mio. | 27 | |
| 201501/01/2015 – 31/12/2015 | 20.4 mio. | 1.3 mio. | 7.6 mio. | 3.6 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 16.2 mio. | 2.4 mio. | 7.6 mio. | 1.8 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 10.9 mio. | 1.5 mio. | 5.2 mio. | 1.2 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 7.8 mio. | 471 t. | 2.7 mio. | 678 t. | - |
Compared to 6.301 companies in Computerkonsulentbistand og forvaltning af computerfaciliteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Epista Life Science A/S is 32141064.
Epista Life Science A/S is owned by Enhance BidCo ApS.
The management of Epista Life Science A/S consists of Per Erik Mikael Johansson.
The board of Epista Life Science A/S consists of Simon Carl Vilhelm Larsson, Katarína Larsen and Klavs Esbjerg, with Simon Carl Vilhelm Larsson as chair.
In 2025, Epista Life Science A/S reported a gross profit of DKK 104,009,512.
Epista Life Science A/S had 92 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 48254500, new email: [email protected], new website: www.epista.com (July 10, 2026).
As of July 1, 2026, Knut Ronny Christer Roos has left the board of directors of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2025. Gross profit came to DKK 104,009,512, and the net result was DKK -40,340,814.
Contact info changed: new phone: 48254500, new email: [email protected], new website: www.epista.com (February 2, 2026).
As of January 31, 2026, Simon Carl Vilhelm Larsson has joined the board of directors of Epista Life Science A/S.
As of January 31, 2026, Maximilian Verfürden Weimann has left the board of directors of Epista Life Science A/S.
As of January 31, 2026, Per Erik Mikael Johansson is registered as adm. dir. of Epista Life Science A/S.
As of January 31, 2026, Klavs Esbjerg has stepped down as adm. dir. of Epista Life Science A/S.
As of August 18, 2025, Maximilian Verfürden Weimann has joined the board of directors of Epista Life Science A/S.
As of August 18, 2025, Line Hyldgaard Hjorth-Christensen has left the board of directors of Epista Life Science A/S.
As of August 18, 2025, Klavs Esbjerg is registered as adm. dir. of Epista Life Science A/S.
As of August 17, 2025, Klavs Esbjerg has stepped down as director of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2024. Gross profit came to DKK 80,942,136, and the net result was DKK -12,458,230.
As of October 23, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Epista Life Science A/S.
As of October 23, 2024, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2023. Gross profit came to DKK 79,704,929, and the net result was DKK 10,497,065.
As of March 1, 2024, Enhance BidCo ApS is registered as an owner of Epista Life Science A/S with an ownership share of 100%.
Epista Life Science A/S has published its annual report for 2022. Gross profit came to DKK 46,783,131, and the net result was DKK 4,723,214.
As of September 5, 2022, Line Hyldgaard Hjorth-Christensen has joined the board of directors of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2021. Gross profit came to DKK 48,207,329, and the net result was DKK 9,105,919.
As of March 1, 2022, Katarína Larsen has joined the board of directors of Epista Life Science A/S.
As of March 1, 2022, Ken Rasmussen has left the board of directors of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2020. Gross profit came to DKK 38,129,000, and the net result was DKK 3,966,919.
Epista Life Science A/S has published its annual report for 2019. Gross profit came to DKK 30,767,570, and the net result was DKK 3,371,740.
Epista Life Science A/S has published its annual report for 2018. Gross profit came to DKK 26,492,705, and the net result was DKK 483,004.
Epista Life Science A/S has published its annual report for 2017. Gross profit came to DKK 23,721,488, and the net result was DKK 1,340,751.
As of August 1, 2017, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Epista Life Science A/S.
As of August 1, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2016. Gross profit came to DKK 19,905,500, and the net result was DKK -884,288.
Epista Life Science A/S has published its annual report for 2015. Gross profit came to DKK 20,392,956, and the net result was DKK 1,325,618.
As of May 19, 2016, Knut Ronny Christer Roos has joined the board of directors of Epista Life Science A/S.
As of May 19, 2016, Mette Pilmann Esbjerg has left the board of directors of Epista Life Science A/S.
On May 19, 2016, the company changed its name from EPISTA IT A/S to Epista Life Science A/S.
As of September 1, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Epista Life Science A/S.
As of September 1, 2015, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2014. Gross profit came to DKK 16,152,951, and the net result was DKK 2,378,521.
Epista Life Science A/S has published its annual report for 2013. Gross profit came to DKK 10,851,968, and the net result was DKK 1,522,575.
As of September 30, 2013, Mette Pilmann Esbjerg has joined the board of directors of Epista Life Science A/S.
As of September 30, 2013, Klavs Esbjerg has joined the board of directors of Epista Life Science A/S.
As of September 30, 2013, Ken Rasmussen has joined the board of directors of Epista Life Science A/S.
On September 30, 2013, the company changed its name from EPISTA IT ApS to EPISTA IT A/S.
Epista Life Science A/S has published its annual report for 2012. Gross profit came to DKK 7,785,482, and the net result was DKK 470,832.
As of October 31, 2012, Martin Woergaard has stepped down as director of Epista Life Science A/S.
As of July 1, 2012, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Epista Life Science A/S.
As of July 1, 2012, Revision Syd I/S has stepped down as auditor of Epista Life Science A/S.
As of April 29, 2009, Revision Syd I/S has been appointed auditor of Epista Life Science A/S.
As of April 29, 2009, Martin Woergaard is registered as director of Epista Life Science A/S.
As of April 29, 2009, Klavs Esbjerg is registered as director of Epista Life Science A/S.
Epista Life Science A/S was founded on April 29, 2009.
Companies in the same industry and area
CVR 34847916
CVR 35336486
CVR 45043622
CVR 39028131
CVR 41139064
